Bunionectomy Clinical Trial
Official title:
Safety and Performance of PEEK Anchors (Dynomite, Spyromite, Raptormite, Footprint Ultra PK SL) in Extremities
| Verified date | June 2020 |
| Source | Smith & Nephew, Inc. |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Observational |
Safety and performance of the study devices in extremities over a time period of 6 months after intervention.
| Status | Completed |
| Enrollment | 122 |
| Est. completion date | August 15, 2019 |
| Est. primary completion date | August 15, 2019 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | All |
| Age group | 18 Years and older |
| Eligibility |
Inclusion Criteria: - Subjects who have undergone extremity joint repair using the study devices. - Subjects aged 18 years and older at the time of surgery. Exclusion Criteria: - Subject is entered in another investigational drug, biologic, or device study or has been treated with an investigational product within 12 months post-operative. - Subjects who are < 3 months post-operative |
| Country | Name | City | State |
|---|---|---|---|
| Canada | Fowler Kennedy Sport Medicine Clinic | London | Ontario |
| United States | Precision Orthopaedic Specialties, Inc. | Chardon | Ohio |
| United States | OrthoCarolina | Charlotte | North Carolina |
| United States | Foot and Ankle Associates of North Texas-Grapevine | Grapevine | Texas |
| United States | Bear Creek Surgery Center | Keller | Texas |
| Lead Sponsor | Collaborator |
|---|---|
| Smith & Nephew, Inc. |
United States, Canada,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Other | Visual Analog Scale (VAS) - pain | 0 to 10 is the scoring range of pain for the joint that received treatment with the anchor | 12 months | |
| Other | Range of Motion (ROM) | Shoulder-full functional arc, forward flexion angle, internal, external rotation will be captured in degrees. | 12 months | |
| Primary | Safety and performance of the study devices in extremities over a time period of 6 months after intervention. | Clinical success is defined as extremity repairs without signs of device failure and/or re-intervention as assessed by the surgeon. | 6 months | |
| Secondary | Safety and performance of the study devices in extremities over a time period of 12 months after intervention | Clinical success is defined as extremity repairs without signs of device failure and/or re-intervention as assessed by the surgeon | 12 months |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00609466 -
A Trial to Evaluate CG5503 Efficacy and Safety in Acute Pain After Bunionectomy
|
Phase 3 | |
| Terminated |
NCT00209560 -
A Study of AQUAVAN® Injection in the Presence of Pre-Medication in Patients Undergoing Minor Surgical Procedures
|
Phase 3 | |
| Completed |
NCT00293631 -
Study of Lornoxicam or Ketorolac or Placebo for Post-Operative Pain After Bunionectomy
|
Phase 2 | |
| Withdrawn |
NCT05087914 -
Novel Non-opioid Post-surgical Pain Treatment in Females
|
Phase 2 | |
| Completed |
NCT04855240 -
Evaluate the Efficacy and Safety of ACP-044 for the Treatment of Acute Postoperative Pain Following Bunionectomy
|
Phase 2 | |
| Completed |
NCT05157841 -
Phase 3, Sciatic Nerve Block With EXPAREL for Subjects Undergoing Bunionectomy
|
Phase 3 |